CVS Health Ventures, the venture capital arm of CVS Health, participated in a $45 million Series A funding round for AI healthcare company Ellipsis Health.
The round was led by Salesforce and Khosla Ventures and coincides with Ellipsis Health’s launch of Sage, its AI care manager, according to a June 12 news release.
Sage is designed to be emotionally intelligent and capable of adjusting its tone and approach based on a patient’s emotional state and mental health needs, according to the company.
Ellipsis Health plans to use the funding to accelerate Sage’s adoption among healthcare providers, payers and care management organizations.
